The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Formulation and coating of microneedles with inactivated influenza virus to improve vaccine stability and immunogenicity
Open accessAbstract
Microneedle patches coated with solid-state influenza vaccine have been developed to improve vaccine efficacy and patient coverage. However, dip coating microneedles with influenza vaccine can reduce antigen activity. In this study, we sought to determine the experimental factors and mechanistic pathways by which inactivated influenza vaccine can lose activity, as well as develop and assess improved microneedle coating formulations that protect the antigen from activity loss. After coating microneedles using a standard vaccine formulation, antigenicity was reduced to just 2%, as measured by hemagglutination activity. The presence of carboxymethylcellulose, which was added to increase viscosity of the coating formulation, was shown to contribute to vaccine activity loss. After screening a panel of candidate stabilizers, the addition of trehalose to the coating formulation was shown to protect the antigen and retain 48–82% antigen activity for all three major strains of seasonal influenza: H1N1, H3N2 and B. Influenza vaccine coated in this way also exhibited thermal stability, such that activity loss was independent of temperature over the range of 4 – 37°C for 24 h. Dynamic light scattering measurements showed that antigen activity loss was associated with virus particle aggregation, and that stabilization using trehalose largely blocked this aggregation. Finally, microneedles using an optimized vaccine coating formulation were applied to the skin to vaccinate mice. Microneedle vaccination induced robust systemic and functional antibodies and provided complete protection against lethal challenge infection similar to conventional intramuscular injection. Overall, these results show that antigen activity loss during microneedle coating can be largely prevented through optimized formulation and that stabilized microneedle patches can be used for effective vaccination.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(2001) · PsycEXTRA Dataset · doi:10.1037/e548312006-001 · Cited by 5,011
Influenza-Associated Hospitalizations in the United States
Thompson, W. W. (2004) · JAMA · doi:10.1001/jama.292.11.1333 · Cited by 2,213 · cited 1×
“Influenza virus is one of the most common causes of serious respiratory illness leading to 20,000 to 50,000 deaths and 95,000 to 110,000 hospitalizations in the United States during a typical influenza season [1,2].”
BackgroundDNA vaccines: protective immunizations by parenteral, mucosal, and gene-gun inoculations.
Fynan, E. F., Webster, R. G., Fuller, D. H., Haynes, J. R., Santoro, J. C., & Robinson, H. L. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.24.11478 · Cited by 1,115
Hobson, D., Curry, R. L., Beare, A. S., & Ward-Gardner, A. (1972) · Epidemiology and Infection · doi:10.1017/s0022172400022610 · Cited by 1,002
Trehalose and sucrose protect both membranes and proteins in intact bacteria during drying
Leslie, S. B., Israeli, E., Lighthart, B., Crowe, J. H., & Crowe, L. M. (1995) · Applied and Environmental Microbiology · doi:10.1128/aem.61.10.3592-3597.1995 · Cited by 977
Stabilization of dry phospholipid bilayers and proteins by sugars
Crowe, J. H., Crowe, L. M., Carpenter, J. F., & Aurell Wistrom, C. (1987) · Biochemical Journal · doi:10.1042/bj2420001 · Cited by 924
Coated microneedles for transdermal delivery
Gill, H. S., & Prausnitz, M. R. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.10.017 · Cited by 765
Self-citationAn infrared spectroscopic study of the interactions of carbohydrates with dried proteins
Carpenter, J. F., & Crowe, J. H. (1989) · Biochemistry · doi:10.1021/bi00435a044 · Cited by 758
Effect of Microneedle Design on Pain in Human Volunteers
Gill, H. S., Denson, D. D., Burris, B. A., & Prausnitz, M. R. (2008) · The Clinical Journal of Pain · doi:10.1097/ajp.0b013e31816778f9 · Cited by 701
Self-citationNicholson, K. G., Wood, J. M., & Zambon, M. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14854-4 · Cited by 691
Cited by
Microneedles for drug and vaccine delivery
Kim, Y.-C., Park, J.-H., & Prausnitz, M. R. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.04.005 · Cited by 1,760
Self-citationMicroneedle technologies for (trans)dermal drug and vaccine delivery
van der Maaden, K., Jiskoot, W., & Bouwstra, J. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.01.042 · Cited by 651
Microneedles for intradermal and transdermal drug delivery
Tuan-Mahmood, T.-M., McCrudden, M. T. C., Torrisi, B. M., McAlister, E., Garland, M. J., Singh, T. R. R., & Donnelly, R. F. (2013) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2013.05.005 · Cited by 468
Microneedles: an emerging transdermal drug delivery system
Bariya, S. H., Gohel, M. C., Mehta, T. A., & Sharma, O. P. (2012) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.2011.01369.x · Cited by 455
Skin permeabilization for transdermal drug delivery: recent advances and future prospects
Schoellhammer, C. M., Blankschtein, D., & Langer, R. (2014) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2014.875528 · Cited by 376
Polymeric microneedles for transdermal protein delivery
Ye, Y., Yu, J., Wen, D., Kahkoska, A. R., & Gu, Z. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.01.015 · Cited by 324
Fabrication of Silk Microneedles for Controlled‐Release Drug Delivery
Tsioris, K., Raja, W. K., Pritchard, E. M., Panilaitis, B., Kaplan, D. L., & Omenetto, F. G. (2012) · Advanced Functional Materials · doi:10.1002/adfm.201102012 · Cited by 301
Dissolving Microneedle Patch for Transdermal Delivery of Human Growth Hormone
Lee, J. W., Choi, S., Felner, E. I., & Prausnitz, M. R. (2011) · Small · doi:10.1002/smll.201001091 · Cited by 301
Self-citationBhatnagar, S., Dave, K., & Venuganti, V. V. K. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.05.029 · Cited by 297
Insulin delivery systems combined with microneedle technology
Jin, X., Zhu, D. D., Chen, B. Z., Ashfaq, M., & Guo, X. D. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.03.011 · Cited by 275
Fully embeddable chitosan microneedles as a sustained release depot for intradermal vaccination
Chen, M.-C., Huang, S.-F., Lai, K.-Y., & Ling, M.-H. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2012.12.041 · Cited by 271
Microneedle array systems for long-acting drug delivery
Vora, L. K., Moffatt, K., Tekko, I. A., Paredes, A. J., Volpe-Zanutto, F., Mishra, D., Peng, K., Raj Singh Thakur, R., & Donnelly, R. F. (2021) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2020.12.006 · Cited by 270
Microneedles as the technique of drug delivery enhancement in diverse organs and tissues
Rzhevskiy, A. S., Singh, T. R. R., Donnelly, R. F., & Anissimov, Y. G. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.11.048 · Cited by 266
Micro Electromechanical Systems (MEMS) Based Microfluidic Devices for Biomedical Applications
Ashraf, M. W., Tayyaba, S., & Afzulpurkar, N. (2011) · International Journal of Molecular Sciences · doi:10.3390/ijms12063648 · Cited by 263
Chitosan Microneedle Patches for Sustained Transdermal Delivery of Macromolecules
Chen, M.-C., Ling, M.-H., Lai, K.-Y., & Pramudityo, E. (2012) · Biomacromolecules · doi:10.1021/bm301293d · Cited by 259
An overview of microneedle applications, materials, and fabrication methods
Faraji Rad, Z., Prewett, P. D., & Davies, G. J. (2021) · Beilstein Journal of Nanotechnology · doi:10.3762/bjnano.12.77 · Cited by 254
Kurhade, R. R., Shaikh, M. S., Nagulwar, V., & Kale, M. A. (2025) · International Journal of Polymeric Materials and Polymeric Biomaterials · doi:10.1080/00914037.2024.2391973 · Cited by 55
Metadata
- Authors
- Kim, Y.-C., Quan, F.-S., Compans, R. W., Kang, S.-M., & Prausnitz, M. R.
- Venue
- Journal of Controlled Release
- Publisher
- Elsevier BV
- Published
- 2010-03
- Volume
- 142
- Issue
- 2
- Pages
- 187-195
- ISSN
- 0168-3659 (ISSN-L)
- OpenAlex
- W2054469972
- Cited by
- 255
- References
- 47
- FWCI
- 11.48
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.